Clinical Trial Update: Study of Velcade and Thalidomide in Patients With Myelodysplasia [Phase 1]

View source ↗

Summary

Phase 1 trial of Velcade (bortezomib) and thalidomide in patients with myelodysplastic syndromes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Thalidomide (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Myelodysplastic Syndrome | Phase 1 | Status: TERMINATED